nodes	percent_of_prediction	percent_of_DWPC	metapath
Felbamate—GRIN2A—melanoma	0.66	1	CbGaD
Felbamate—CYP2E1—Dacarbazine—melanoma	0.0666	0.444	CbGbCtD
Felbamate—CYP3A4—Temozolomide—melanoma	0.0481	0.32	CbGbCtD
Felbamate—CYP3A4—Vemurafenib—melanoma	0.0263	0.175	CbGbCtD
Felbamate—CYP3A4—Docetaxel—melanoma	0.00903	0.0602	CbGbCtD
Felbamate—Lacosamide—SCN10A—melanoma	0.000513	1	CrCbGaD
Felbamate—Hyperglycaemia—Temozolomide—melanoma	0.000285	0.00201	CcSEcCtD
Felbamate—Urinary tract infection—Carmustine—melanoma	0.000284	0.002	CcSEcCtD
Felbamate—Pneumonia—Temozolomide—melanoma	0.000284	0.002	CcSEcCtD
Felbamate—Depression—Temozolomide—melanoma	0.000281	0.00198	CcSEcCtD
Felbamate—Thrombophlebitis—Docetaxel—melanoma	0.000281	0.00198	CcSEcCtD
Felbamate—Hepatitis—Dactinomycin—melanoma	0.00028	0.00197	CcSEcCtD
Felbamate—Blood alkaline phosphatase increased—Docetaxel—melanoma	0.00028	0.00197	CcSEcCtD
Felbamate—Stevens-Johnson syndrome—Temozolomide—melanoma	0.00028	0.00197	CcSEcCtD
Felbamate—Flushing—Bleomycin—melanoma	0.000279	0.00196	CcSEcCtD
Felbamate—Body temperature increased—Vemurafenib—melanoma	0.000278	0.00196	CcSEcCtD
Felbamate—Pharyngitis—Dactinomycin—melanoma	0.000278	0.00195	CcSEcCtD
Felbamate—Urinary tract infection—Temozolomide—melanoma	0.000274	0.00193	CcSEcCtD
Felbamate—Hepatic failure—Docetaxel—melanoma	0.000271	0.00191	CcSEcCtD
Felbamate—Chills—Bleomycin—melanoma	0.000269	0.0019	CcSEcCtD
Felbamate—Alopecia—Bleomycin—melanoma	0.000265	0.00187	CcSEcCtD
Felbamate—Erythema multiforme—Dactinomycin—melanoma	0.000265	0.00186	CcSEcCtD
Felbamate—Sinusitis—Temozolomide—melanoma	0.000265	0.00186	CcSEcCtD
Felbamate—Haemoglobin—Carmustine—melanoma	0.000263	0.00185	CcSEcCtD
Felbamate—Haemorrhage—Carmustine—melanoma	0.000262	0.00184	CcSEcCtD
Felbamate—Hallucination—Carmustine—melanoma	0.000261	0.00183	CcSEcCtD
Felbamate—Flushing—Dactinomycin—melanoma	0.00026	0.00183	CcSEcCtD
Felbamate—Atrial fibrillation—Docetaxel—melanoma	0.000257	0.00181	CcSEcCtD
Felbamate—Renal impairment—Docetaxel—melanoma	0.000256	0.0018	CcSEcCtD
Felbamate—Dermatitis bullous—Docetaxel—melanoma	0.000255	0.00179	CcSEcCtD
Felbamate—Haemoglobin—Temozolomide—melanoma	0.000254	0.00179	CcSEcCtD
Felbamate—Haemorrhage—Temozolomide—melanoma	0.000253	0.00178	CcSEcCtD
Felbamate—Hepatitis—Temozolomide—melanoma	0.000253	0.00178	CcSEcCtD
Felbamate—Asthenia—Vemurafenib—melanoma	0.000253	0.00178	CcSEcCtD
Felbamate—Visual impairment—Carmustine—melanoma	0.000252	0.00178	CcSEcCtD
Felbamate—Hallucination—Temozolomide—melanoma	0.000252	0.00177	CcSEcCtD
Felbamate—Pharyngitis—Temozolomide—melanoma	0.000251	0.00177	CcSEcCtD
Felbamate—Chills—Dactinomycin—melanoma	0.000251	0.00177	CcSEcCtD
Felbamate—Cardiac failure—Docetaxel—melanoma	0.000249	0.00175	CcSEcCtD
Felbamate—Pruritus—Vemurafenib—melanoma	0.000249	0.00175	CcSEcCtD
Felbamate—Alopecia—Dactinomycin—melanoma	0.000247	0.00174	CcSEcCtD
Felbamate—Hyponatraemia—Docetaxel—melanoma	0.000244	0.00172	CcSEcCtD
Felbamate—Visual impairment—Temozolomide—melanoma	0.000244	0.00172	CcSEcCtD
Felbamate—Flushing—Carmustine—melanoma	0.000243	0.00171	CcSEcCtD
Felbamate—Ill-defined disorder—Bleomycin—melanoma	0.000242	0.00171	CcSEcCtD
Felbamate—Anaemia—Bleomycin—melanoma	0.000241	0.0017	CcSEcCtD
Felbamate—Diarrhoea—Vemurafenib—melanoma	0.000241	0.00169	CcSEcCtD
Felbamate—Migraine—Docetaxel—melanoma	0.00024	0.00169	CcSEcCtD
Felbamate—Erythema multiforme—Temozolomide—melanoma	0.000239	0.00168	CcSEcCtD
Felbamate—Malaise—Bleomycin—melanoma	0.000236	0.00166	CcSEcCtD
Felbamate—Flushing—Temozolomide—melanoma	0.000235	0.00165	CcSEcCtD
Felbamate—Leukopenia—Bleomycin—melanoma	0.000234	0.00165	CcSEcCtD
Felbamate—Dizziness—Vemurafenib—melanoma	0.000233	0.00164	CcSEcCtD
Felbamate—Alopecia—Carmustine—melanoma	0.000231	0.00163	CcSEcCtD
Felbamate—Ataxia—Docetaxel—melanoma	0.000229	0.00161	CcSEcCtD
Felbamate—Cough—Bleomycin—melanoma	0.000228	0.0016	CcSEcCtD
Felbamate—Chills—Temozolomide—melanoma	0.000227	0.0016	CcSEcCtD
Felbamate—Dehydration—Docetaxel—melanoma	0.000226	0.00159	CcSEcCtD
Felbamate—Ill-defined disorder—Dactinomycin—melanoma	0.000226	0.00159	CcSEcCtD
Felbamate—Anaemia—Dactinomycin—melanoma	0.000225	0.00158	CcSEcCtD
Felbamate—Vomiting—Vemurafenib—melanoma	0.000224	0.00157	CcSEcCtD
Felbamate—Alopecia—Temozolomide—melanoma	0.000224	0.00157	CcSEcCtD
Felbamate—Chest pain—Bleomycin—melanoma	0.000222	0.00157	CcSEcCtD
Felbamate—Myalgia—Bleomycin—melanoma	0.000222	0.00157	CcSEcCtD
Felbamate—Rash—Vemurafenib—melanoma	0.000222	0.00156	CcSEcCtD
Felbamate—Dermatitis—Vemurafenib—melanoma	0.000222	0.00156	CcSEcCtD
Felbamate—Headache—Vemurafenib—melanoma	0.00022	0.00155	CcSEcCtD
Felbamate—Discomfort—Bleomycin—melanoma	0.00022	0.00155	CcSEcCtD
Felbamate—Malaise—Dactinomycin—melanoma	0.00022	0.00155	CcSEcCtD
Felbamate—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000219	0.00154	CcSEcCtD
Felbamate—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000219	0.00154	CcSEcCtD
Felbamate—Leukopenia—Dactinomycin—melanoma	0.000218	0.00153	CcSEcCtD
Felbamate—Dysgeusia—Temozolomide—melanoma	0.000216	0.00152	CcSEcCtD
Felbamate—Confusional state—Bleomycin—melanoma	0.000215	0.00151	CcSEcCtD
Felbamate—Alanine aminotransferase increased—Docetaxel—melanoma	0.000215	0.00151	CcSEcCtD
Felbamate—Tremor—Carmustine—melanoma	0.000214	0.0015	CcSEcCtD
Felbamate—Oedema—Bleomycin—melanoma	0.000213	0.0015	CcSEcCtD
Felbamate—Anaphylactic shock—Bleomycin—melanoma	0.000213	0.0015	CcSEcCtD
Felbamate—Infection—Bleomycin—melanoma	0.000212	0.00149	CcSEcCtD
Felbamate—Anaemia—Carmustine—melanoma	0.000211	0.00148	CcSEcCtD
Felbamate—Dysphagia—Docetaxel—melanoma	0.00021	0.00148	CcSEcCtD
Felbamate—Agitation—Carmustine—melanoma	0.00021	0.00147	CcSEcCtD
Felbamate—Nausea—Vemurafenib—melanoma	0.000209	0.00147	CcSEcCtD
Felbamate—Thrombocytopenia—Bleomycin—melanoma	0.000209	0.00147	CcSEcCtD
Felbamate—Myalgia—Dactinomycin—melanoma	0.000207	0.00146	CcSEcCtD
Felbamate—Tremor—Temozolomide—melanoma	0.000206	0.00145	CcSEcCtD
Felbamate—Discomfort—Dactinomycin—melanoma	0.000205	0.00144	CcSEcCtD
Felbamate—Ill-defined disorder—Temozolomide—melanoma	0.000204	0.00144	CcSEcCtD
Felbamate—Leukopenia—Carmustine—melanoma	0.000204	0.00144	CcSEcCtD
Felbamate—Anaemia—Temozolomide—melanoma	0.000204	0.00143	CcSEcCtD
Felbamate—Anorexia—Bleomycin—melanoma	0.000203	0.00143	CcSEcCtD
Felbamate—Agitation—Temozolomide—melanoma	0.000203	0.00143	CcSEcCtD
Felbamate—Pancytopenia—Docetaxel—melanoma	0.0002	0.00141	CcSEcCtD
Felbamate—Hypotension—Bleomycin—melanoma	0.000199	0.0014	CcSEcCtD
Felbamate—Oedema—Dactinomycin—melanoma	0.000199	0.0014	CcSEcCtD
Felbamate—Malaise—Temozolomide—melanoma	0.000199	0.0014	CcSEcCtD
Felbamate—Infection—Dactinomycin—melanoma	0.000198	0.00139	CcSEcCtD
Felbamate—Leukopenia—Temozolomide—melanoma	0.000197	0.00139	CcSEcCtD
Felbamate—Hypertension—Carmustine—melanoma	0.000197	0.00139	CcSEcCtD
Felbamate—Palpitations—Temozolomide—melanoma	0.000195	0.00137	CcSEcCtD
Felbamate—Thrombocytopenia—Dactinomycin—melanoma	0.000195	0.00137	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Bleomycin—melanoma	0.000194	0.00137	CcSEcCtD
Felbamate—Chest pain—Carmustine—melanoma	0.000194	0.00137	CcSEcCtD
Felbamate—Myalgia—Carmustine—melanoma	0.000194	0.00137	CcSEcCtD
Felbamate—Anxiety—Carmustine—melanoma	0.000193	0.00136	CcSEcCtD
Felbamate—Cough—Temozolomide—melanoma	0.000192	0.00135	CcSEcCtD
Felbamate—Paraesthesia—Bleomycin—melanoma	0.000191	0.00135	CcSEcCtD
Felbamate—Weight increased—Docetaxel—melanoma	0.000191	0.00135	CcSEcCtD
Felbamate—Weight decreased—Docetaxel—melanoma	0.00019	0.00134	CcSEcCtD
Felbamate—Hypertension—Temozolomide—melanoma	0.00019	0.00134	CcSEcCtD
Felbamate—Dyspnoea—Bleomycin—melanoma	0.00019	0.00134	CcSEcCtD
Felbamate—Anorexia—Dactinomycin—melanoma	0.00019	0.00133	CcSEcCtD
Felbamate—Pneumonia—Docetaxel—melanoma	0.000189	0.00133	CcSEcCtD
Felbamate—Confusional state—Carmustine—melanoma	0.000188	0.00132	CcSEcCtD
Felbamate—Myalgia—Temozolomide—melanoma	0.000188	0.00132	CcSEcCtD
Felbamate—Arthralgia—Temozolomide—melanoma	0.000188	0.00132	CcSEcCtD
Felbamate—Anxiety—Temozolomide—melanoma	0.000187	0.00132	CcSEcCtD
Felbamate—Oedema—Carmustine—melanoma	0.000186	0.00131	CcSEcCtD
Felbamate—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000186	0.00131	CcSEcCtD
Felbamate—Discomfort—Temozolomide—melanoma	0.000185	0.0013	CcSEcCtD
Felbamate—Decreased appetite—Bleomycin—melanoma	0.000185	0.0013	CcSEcCtD
Felbamate—Infection—Carmustine—melanoma	0.000185	0.0013	CcSEcCtD
Felbamate—Dry mouth—Temozolomide—melanoma	0.000183	0.00129	CcSEcCtD
Felbamate—Jaundice—Docetaxel—melanoma	0.000183	0.00129	CcSEcCtD
Felbamate—Pain—Bleomycin—melanoma	0.000182	0.00128	CcSEcCtD
Felbamate—Conjunctivitis—Docetaxel—melanoma	0.000182	0.00128	CcSEcCtD
Felbamate—Thrombocytopenia—Carmustine—melanoma	0.000182	0.00128	CcSEcCtD
Felbamate—Tachycardia—Carmustine—melanoma	0.000182	0.00128	CcSEcCtD
Felbamate—Confusional state—Temozolomide—melanoma	0.000181	0.00128	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000181	0.00127	CcSEcCtD
Felbamate—Oedema—Temozolomide—melanoma	0.00018	0.00127	CcSEcCtD
Felbamate—Anaphylactic shock—Temozolomide—melanoma	0.00018	0.00127	CcSEcCtD
Felbamate—Infection—Temozolomide—melanoma	0.000179	0.00126	CcSEcCtD
Felbamate—Anorexia—Carmustine—melanoma	0.000177	0.00125	CcSEcCtD
Felbamate—Epistaxis—Docetaxel—melanoma	0.000177	0.00124	CcSEcCtD
Felbamate—Thrombocytopenia—Temozolomide—melanoma	0.000176	0.00124	CcSEcCtD
Felbamate—Feeling abnormal—Bleomycin—melanoma	0.000176	0.00124	CcSEcCtD
Felbamate—Agranulocytosis—Docetaxel—melanoma	0.000175	0.00123	CcSEcCtD
Felbamate—Hypotension—Carmustine—melanoma	0.000174	0.00122	CcSEcCtD
Felbamate—Hyperhidrosis—Temozolomide—melanoma	0.000174	0.00122	CcSEcCtD
Felbamate—Decreased appetite—Dactinomycin—melanoma	0.000173	0.00122	CcSEcCtD
Felbamate—Fatigue—Dactinomycin—melanoma	0.000171	0.00121	CcSEcCtD
Felbamate—Anorexia—Temozolomide—melanoma	0.000171	0.00121	CcSEcCtD
Felbamate—Pain—Dactinomycin—melanoma	0.00017	0.0012	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Carmustine—melanoma	0.00017	0.00119	CcSEcCtD
Felbamate—Urticaria—Bleomycin—melanoma	0.000169	0.00119	CcSEcCtD
Felbamate—Haemoglobin—Docetaxel—melanoma	0.000169	0.00119	CcSEcCtD
Felbamate—Rhinitis—Docetaxel—melanoma	0.000169	0.00119	CcSEcCtD
Felbamate—Body temperature increased—Bleomycin—melanoma	0.000169	0.00119	CcSEcCtD
Felbamate—Haemorrhage—Docetaxel—melanoma	0.000168	0.00118	CcSEcCtD
Felbamate—Hepatitis—Docetaxel—melanoma	0.000168	0.00118	CcSEcCtD
Felbamate—Insomnia—Carmustine—melanoma	0.000168	0.00118	CcSEcCtD
Felbamate—Paraesthesia—Carmustine—melanoma	0.000167	0.00118	CcSEcCtD
Felbamate—Pharyngitis—Docetaxel—melanoma	0.000167	0.00118	CcSEcCtD
Felbamate—Dyspnoea—Carmustine—melanoma	0.000166	0.00117	CcSEcCtD
Felbamate—Somnolence—Carmustine—melanoma	0.000165	0.00116	CcSEcCtD
Felbamate—Feeling abnormal—Dactinomycin—melanoma	0.000164	0.00115	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Temozolomide—melanoma	0.000164	0.00115	CcSEcCtD
Felbamate—Insomnia—Temozolomide—melanoma	0.000163	0.00114	CcSEcCtD
Felbamate—Gastrointestinal pain—Dactinomycin—melanoma	0.000163	0.00114	CcSEcCtD
Felbamate—Visual impairment—Docetaxel—melanoma	0.000162	0.00114	CcSEcCtD
Felbamate—Decreased appetite—Carmustine—melanoma	0.000162	0.00114	CcSEcCtD
Felbamate—Paraesthesia—Temozolomide—melanoma	0.000162	0.00114	CcSEcCtD
Felbamate—Dyspnoea—Temozolomide—melanoma	0.00016	0.00113	CcSEcCtD
Felbamate—Somnolence—Temozolomide—melanoma	0.00016	0.00113	CcSEcCtD
Felbamate—Erythema multiforme—Docetaxel—melanoma	0.000159	0.00112	CcSEcCtD
Felbamate—Constipation—Carmustine—melanoma	0.000159	0.00112	CcSEcCtD
Felbamate—Pain—Carmustine—melanoma	0.000159	0.00112	CcSEcCtD
Felbamate—Dyspepsia—Temozolomide—melanoma	0.000158	0.00111	CcSEcCtD
Felbamate—Abdominal pain—Dactinomycin—melanoma	0.000157	0.00111	CcSEcCtD
Felbamate—Body temperature increased—Dactinomycin—melanoma	0.000157	0.00111	CcSEcCtD
Felbamate—Decreased appetite—Temozolomide—melanoma	0.000156	0.0011	CcSEcCtD
Felbamate—Flushing—Docetaxel—melanoma	0.000156	0.0011	CcSEcCtD
Felbamate—Fatigue—Temozolomide—melanoma	0.000155	0.00109	CcSEcCtD
Felbamate—Pain—Temozolomide—melanoma	0.000154	0.00108	CcSEcCtD
Felbamate—Constipation—Temozolomide—melanoma	0.000154	0.00108	CcSEcCtD
Felbamate—Feeling abnormal—Carmustine—melanoma	0.000153	0.00108	CcSEcCtD
Felbamate—Asthenia—Bleomycin—melanoma	0.000153	0.00108	CcSEcCtD
Felbamate—Gastrointestinal pain—Carmustine—melanoma	0.000152	0.00107	CcSEcCtD
Felbamate—Chills—Docetaxel—melanoma	0.000151	0.00106	CcSEcCtD
Felbamate—Pruritus—Bleomycin—melanoma	0.000151	0.00106	CcSEcCtD
Felbamate—Alopecia—Docetaxel—melanoma	0.000149	0.00105	CcSEcCtD
Felbamate—Feeling abnormal—Temozolomide—melanoma	0.000148	0.00104	CcSEcCtD
Felbamate—Body temperature increased—Carmustine—melanoma	0.000147	0.00104	CcSEcCtD
Felbamate—Abdominal pain—Carmustine—melanoma	0.000147	0.00104	CcSEcCtD
Felbamate—Gastrointestinal pain—Temozolomide—melanoma	0.000147	0.00104	CcSEcCtD
Felbamate—Dysgeusia—Docetaxel—melanoma	0.000144	0.00101	CcSEcCtD
Felbamate—Urticaria—Temozolomide—melanoma	0.000143	0.00101	CcSEcCtD
Felbamate—Asthenia—Dactinomycin—melanoma	0.000143	0.001	CcSEcCtD
Felbamate—Abdominal pain—Temozolomide—melanoma	0.000142	0.001	CcSEcCtD
Felbamate—Body temperature increased—Temozolomide—melanoma	0.000142	0.001	CcSEcCtD
Felbamate—Diarrhoea—Dactinomycin—melanoma	0.000136	0.000957	CcSEcCtD
Felbamate—Vomiting—Bleomycin—melanoma	0.000136	0.000954	CcSEcCtD
Felbamate—Anaemia—Docetaxel—melanoma	0.000135	0.000953	CcSEcCtD
Felbamate—Rash—Bleomycin—melanoma	0.000134	0.000946	CcSEcCtD
Felbamate—Dermatitis—Bleomycin—melanoma	0.000134	0.000945	CcSEcCtD
Felbamate—Asthenia—Carmustine—melanoma	0.000134	0.00094	CcSEcCtD
Felbamate—Leukopenia—Docetaxel—melanoma	0.000131	0.000923	CcSEcCtD
Felbamate—Palpitations—Docetaxel—melanoma	0.00013	0.000911	CcSEcCtD
Felbamate—Asthenia—Temozolomide—melanoma	0.000129	0.000908	CcSEcCtD
Felbamate—Cough—Docetaxel—melanoma	0.000128	0.0009	CcSEcCtD
Felbamate—Diarrhoea—Carmustine—melanoma	0.000127	0.000896	CcSEcCtD
Felbamate—Pruritus—Temozolomide—melanoma	0.000127	0.000895	CcSEcCtD
Felbamate—Nausea—Bleomycin—melanoma	0.000127	0.000891	CcSEcCtD
Felbamate—Hypertension—Docetaxel—melanoma	0.000127	0.00089	CcSEcCtD
Felbamate—Vomiting—Dactinomycin—melanoma	0.000126	0.00089	CcSEcCtD
Felbamate—Rash—Dactinomycin—melanoma	0.000125	0.000882	CcSEcCtD
Felbamate—Arthralgia—Docetaxel—melanoma	0.000125	0.000878	CcSEcCtD
Felbamate—Chest pain—Docetaxel—melanoma	0.000125	0.000878	CcSEcCtD
Felbamate—Myalgia—Docetaxel—melanoma	0.000125	0.000878	CcSEcCtD
Felbamate—Dizziness—Carmustine—melanoma	0.000123	0.000866	CcSEcCtD
Felbamate—Diarrhoea—Temozolomide—melanoma	0.000123	0.000866	CcSEcCtD
Felbamate—Dry mouth—Docetaxel—melanoma	0.000122	0.000859	CcSEcCtD
Felbamate—Confusional state—Docetaxel—melanoma	0.000121	0.000849	CcSEcCtD
Felbamate—Anaphylactic shock—Docetaxel—melanoma	0.00012	0.000842	CcSEcCtD
Felbamate—Oedema—Docetaxel—melanoma	0.00012	0.000842	CcSEcCtD
Felbamate—Dizziness—Temozolomide—melanoma	0.000119	0.000837	CcSEcCtD
Felbamate—Infection—Docetaxel—melanoma	0.000119	0.000836	CcSEcCtD
Felbamate—Vomiting—Carmustine—melanoma	0.000118	0.000833	CcSEcCtD
Felbamate—Nausea—Dactinomycin—melanoma	0.000118	0.000831	CcSEcCtD
Felbamate—Rash—Carmustine—melanoma	0.000117	0.000826	CcSEcCtD
Felbamate—Dermatitis—Carmustine—melanoma	0.000117	0.000825	CcSEcCtD
Felbamate—Thrombocytopenia—Docetaxel—melanoma	0.000117	0.000824	CcSEcCtD
Felbamate—Tachycardia—Docetaxel—melanoma	0.000117	0.000822	CcSEcCtD
Felbamate—Headache—Carmustine—melanoma	0.000117	0.000821	CcSEcCtD
Felbamate—Vomiting—Temozolomide—melanoma	0.000114	0.000805	CcSEcCtD
Felbamate—Anorexia—Docetaxel—melanoma	0.000114	0.000802	CcSEcCtD
Felbamate—Rash—Temozolomide—melanoma	0.000113	0.000798	CcSEcCtD
Felbamate—Dermatitis—Temozolomide—melanoma	0.000113	0.000797	CcSEcCtD
Felbamate—Headache—Temozolomide—melanoma	0.000113	0.000793	CcSEcCtD
Felbamate—Hypotension—Docetaxel—melanoma	0.000112	0.000787	CcSEcCtD
Felbamate—Nausea—Carmustine—melanoma	0.000111	0.000778	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Docetaxel—melanoma	0.000109	0.000767	CcSEcCtD
Felbamate—Insomnia—Docetaxel—melanoma	0.000108	0.000761	CcSEcCtD
Felbamate—Paraesthesia—Docetaxel—melanoma	0.000107	0.000756	CcSEcCtD
Felbamate—Nausea—Temozolomide—melanoma	0.000107	0.000752	CcSEcCtD
Felbamate—Dyspnoea—Docetaxel—melanoma	0.000107	0.00075	CcSEcCtD
Felbamate—Somnolence—Docetaxel—melanoma	0.000106	0.000748	CcSEcCtD
Felbamate—Dyspepsia—Docetaxel—melanoma	0.000105	0.000741	CcSEcCtD
Felbamate—Decreased appetite—Docetaxel—melanoma	0.000104	0.000732	CcSEcCtD
Felbamate—Fatigue—Docetaxel—melanoma	0.000103	0.000726	CcSEcCtD
Felbamate—Pain—Docetaxel—melanoma	0.000102	0.00072	CcSEcCtD
Felbamate—Constipation—Docetaxel—melanoma	0.000102	0.00072	CcSEcCtD
Felbamate—Feeling abnormal—Docetaxel—melanoma	9.86e-05	0.000694	CcSEcCtD
Felbamate—Gastrointestinal pain—Docetaxel—melanoma	9.78e-05	0.000688	CcSEcCtD
Felbamate—Abdominal pain—Docetaxel—melanoma	9.46e-05	0.000665	CcSEcCtD
Felbamate—Body temperature increased—Docetaxel—melanoma	9.46e-05	0.000665	CcSEcCtD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	9.35e-05	0.00197	CbGpPWpGaD
Felbamate—GRIN2A—Alzheimers Disease—TNF—melanoma	9.34e-05	0.00197	CbGpPWpGaD
Felbamate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—melanoma	9.21e-05	0.00194	CbGpPWpGaD
Felbamate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—melanoma	9.08e-05	0.00191	CbGpPWpGaD
Felbamate—GRIN2B—EPH-Ephrin signaling—MMP9—melanoma	8.98e-05	0.00189	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—UGT2B10—melanoma	8.96e-05	0.00189	CbGpPWpGaD
Felbamate—GRIN2B—Alzheimers Disease—MAPK3—melanoma	8.77e-05	0.00185	CbGpPWpGaD
Felbamate—Asthenia—Docetaxel—melanoma	8.58e-05	0.000604	CcSEcCtD
Felbamate—GRIN2B—Developmental Biology—RAC2—melanoma	8.55e-05	0.0018	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—MAP2K1—melanoma	8.48e-05	0.00179	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—PRKCA—melanoma	8.48e-05	0.00178	CbGpPWpGaD
Felbamate—Pruritus—Docetaxel—melanoma	8.46e-05	0.000596	CcSEcCtD
Felbamate—GRIN2B—Alzheimers Disease—MAPK1—melanoma	8.34e-05	0.00176	CbGpPWpGaD
Felbamate—GRIN2A—Alzheimers Disease—TP53—melanoma	8.23e-05	0.00173	CbGpPWpGaD
Felbamate—Diarrhoea—Docetaxel—melanoma	8.18e-05	0.000576	CcSEcCtD
Felbamate—GRIN2B—Developmental Biology—CDH2—melanoma	8.17e-05	0.00172	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—BRAF—melanoma	8.15e-05	0.00172	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—ITGAV—melanoma	8.12e-05	0.00171	CbGpPWpGaD
Felbamate—GRIN2B—EPH-Ephrin signaling—VEGFA—melanoma	8.06e-05	0.0017	CbGpPWpGaD
Felbamate—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—melanoma	7.95e-05	0.00167	CbGpPWpGaD
Felbamate—GRIN2B—Alzheimers Disease—TNF—melanoma	7.94e-05	0.00167	CbGpPWpGaD
Felbamate—Dizziness—Docetaxel—melanoma	7.91e-05	0.000557	CcSEcCtD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	7.87e-05	0.00166	CbGpPWpGaD
Felbamate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—melanoma	7.72e-05	0.00163	CbGpPWpGaD
Felbamate—Vomiting—Docetaxel—melanoma	7.6e-05	0.000535	CcSEcCtD
Felbamate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—melanoma	7.57e-05	0.00159	CbGpPWpGaD
Felbamate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—melanoma	7.56e-05	0.00159	CbGpPWpGaD
Felbamate—Rash—Docetaxel—melanoma	7.54e-05	0.000531	CcSEcCtD
Felbamate—Dermatitis—Docetaxel—melanoma	7.53e-05	0.00053	CcSEcCtD
Felbamate—Headache—Docetaxel—melanoma	7.49e-05	0.000527	CcSEcCtD
Felbamate—GRIN2B—Axon guidance—ITGB1—melanoma	7.38e-05	0.00155	CbGpPWpGaD
Felbamate—CYP2E1—Tryptophan metabolism—MDM2—melanoma	7.28e-05	0.00153	CbGpPWpGaD
Felbamate—CYP3A4—Tryptophan metabolism—CYP1B1—melanoma	7.22e-05	0.00152	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—PRKCA—melanoma	7.21e-05	0.00152	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—PAX6—melanoma	7.19e-05	0.00151	CbGpPWpGaD
Felbamate—Nausea—Docetaxel—melanoma	7.1e-05	0.0005	CcSEcCtD
Felbamate—GRIN2B—Alzheimers Disease—TP53—melanoma	7e-05	0.00147	CbGpPWpGaD
Felbamate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	6.94e-05	0.00146	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—BRAF—melanoma	6.93e-05	0.00146	CbGpPWpGaD
Felbamate—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—melanoma	6.84e-05	0.00144	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—MDM2—melanoma	6.83e-05	0.00144	CbGpPWpGaD
Felbamate—CYP2C19—Melatonin metabolism and effects—NFKB1—melanoma	6.79e-05	0.00143	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—CASP3—melanoma	6.75e-05	0.00142	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—CTNNB1—melanoma	6.51e-05	0.00137	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—CYP17A1—melanoma	6.44e-05	0.00136	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—ITGB3—melanoma	6.4e-05	0.00135	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—CYP17A1—melanoma	6.35e-05	0.00134	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—NFKB1—melanoma	6.32e-05	0.00133	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—ACER3—melanoma	6.26e-05	0.00132	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—MAP2K2—melanoma	6.25e-05	0.00132	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—BRAF—melanoma	6.24e-05	0.00131	CbGpPWpGaD
Felbamate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	6.21e-05	0.00131	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—RAC1—melanoma	5.93e-05	0.00125	CbGpPWpGaD
Felbamate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	5.84e-05	0.00123	CbGpPWpGaD
Felbamate—GRIN2B—EPH-Ephrin signaling—HRAS—melanoma	5.83e-05	0.00123	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—MDM2—melanoma	5.8e-05	0.00122	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—ITGAV—melanoma	5.8e-05	0.00122	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—AKT3—melanoma	5.8e-05	0.00122	CbGpPWpGaD
Felbamate—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—melanoma	5.76e-05	0.00121	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—AKR1B10—melanoma	5.7e-05	0.0012	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—STAT3—melanoma	5.68e-05	0.00119	CbGpPWpGaD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	5.62e-05	0.00118	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—KDR—melanoma	5.44e-05	0.00114	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—MAPK3—melanoma	5.42e-05	0.00114	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—CYP1B1—melanoma	5.42e-05	0.00114	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—CYP1B1—melanoma	5.34e-05	0.00113	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—MET—melanoma	5.32e-05	0.00112	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—BRAF—melanoma	5.31e-05	0.00112	CbGpPWpGaD
Felbamate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	5.28e-05	0.00111	CbGpPWpGaD
Felbamate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	5.27e-05	0.00111	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—ITGB1—melanoma	5.26e-05	0.00111	CbGpPWpGaD
Felbamate—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—melanoma	5.25e-05	0.00111	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—MDM2—melanoma	5.23e-05	0.0011	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—MAPK1—melanoma	5.16e-05	0.00109	CbGpPWpGaD
Felbamate—CYP2C19—Arachidonic acid metabolism—PTGS2—melanoma	5.06e-05	0.00107	CbGpPWpGaD
Felbamate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	4.98e-05	0.00105	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—CYP17A1—melanoma	4.97e-05	0.00105	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—CYP17A1—melanoma	4.9e-05	0.00103	CbGpPWpGaD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	4.73e-05	0.000996	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—MAPK1—melanoma	4.67e-05	0.000982	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—ITGB3—melanoma	4.56e-05	0.000961	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—MAP2K2—melanoma	4.46e-05	0.000939	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—MDM2—melanoma	4.45e-05	0.000936	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—MMP2—melanoma	4.44e-05	0.000935	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—MAP2K1—melanoma	4.43e-05	0.000933	CbGpPWpGaD
Felbamate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	4.24e-05	0.000892	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—RAC1—melanoma	4.23e-05	0.000891	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—CYP1B1—melanoma	4.18e-05	0.00088	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—HRAS—melanoma	4.14e-05	0.000872	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—CYP1B1—melanoma	4.12e-05	0.000868	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—MAPK1—melanoma	3.97e-05	0.000835	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—ERBB2—melanoma	3.89e-05	0.000819	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—KDR—melanoma	3.88e-05	0.000817	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—MET—melanoma	3.8e-05	0.0008	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—CDK4—melanoma	3.8e-05	0.0008	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	3.79e-05	0.000798	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—HRAS—melanoma	3.75e-05	0.000789	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—AKT1—melanoma	3.66e-05	0.00077	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—NOTCH1—melanoma	3.66e-05	0.00077	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ACER3—melanoma	3.61e-05	0.000761	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—MAPK1—melanoma	3.57e-05	0.000753	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—PPARG—melanoma	3.45e-05	0.000726	CbGpPWpGaD
Felbamate—CYP3A4—Tryptophan metabolism—MDM2—melanoma	3.38e-05	0.000711	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—MMP9—melanoma	3.34e-05	0.000702	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—UGT2B10—melanoma	3.3e-05	0.000696	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—HRAS—melanoma	3.18e-05	0.000671	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—MMP2—melanoma	3.17e-05	0.000667	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CUBN—melanoma	3.16e-05	0.000666	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—MAP2K1—melanoma	3.16e-05	0.000666	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—HS3ST5—melanoma	3.07e-05	0.000647	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—MAPK1—melanoma	3.04e-05	0.00064	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—FGF2—melanoma	3.01e-05	0.000634	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—VEGFA—melanoma	3e-05	0.000631	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—CYP17A1—melanoma	2.99e-05	0.000629	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—GPAM—melanoma	2.96e-05	0.000623	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—NRAS—melanoma	2.96e-05	0.000623	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	2.95e-05	0.00062	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—HRAS—melanoma	2.87e-05	0.000604	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—MAPK3—melanoma	2.83e-05	0.000597	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ACER3—melanoma	2.79e-05	0.000587	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—ERBB2—melanoma	2.78e-05	0.000584	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—MAPK1—melanoma	2.7e-05	0.000568	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—EGFR—melanoma	2.7e-05	0.000568	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—UGT2B10—melanoma	2.55e-05	0.000537	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—KRAS—melanoma	2.55e-05	0.000536	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	2.52e-05	0.00053	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—CYP1B1—melanoma	2.51e-05	0.000529	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	2.48e-05	0.000522	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—HRAS—melanoma	2.44e-05	0.000514	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—CTNNB1—melanoma	2.43e-05	0.000511	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—MMP9—melanoma	2.38e-05	0.000501	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—HS3ST5—melanoma	2.37e-05	0.000499	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—NFKB1—melanoma	2.36e-05	0.000496	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PLCB4—melanoma	2.33e-05	0.00049	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—SLC6A11—melanoma	2.19e-05	0.000461	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PIP4K2A—melanoma	2.19e-05	0.000461	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—HRAS—melanoma	2.16e-05	0.000456	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—VEGFA—melanoma	2.14e-05	0.00045	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—MTAP—melanoma	2.13e-05	0.000448	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—STAT3—melanoma	2.12e-05	0.000446	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—NRAS—melanoma	2.11e-05	0.000445	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—IL6—melanoma	2.07e-05	0.000436	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—MAPK3—melanoma	2.02e-05	0.000426	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—MAPK1—melanoma	1.92e-05	0.000405	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—EGFR—melanoma	1.92e-05	0.000405	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	1.91e-05	0.000402	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—LUM—melanoma	1.9e-05	0.0004	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PHGDH—melanoma	1.9e-05	0.0004	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—HPSE—melanoma	1.86e-05	0.000392	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—TNF—melanoma	1.83e-05	0.000386	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CUBN—melanoma	1.83e-05	0.000385	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—KRAS—melanoma	1.82e-05	0.000383	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PLCB4—melanoma	1.8e-05	0.000378	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—SDHD—melanoma	1.76e-05	0.000371	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CSPG4—melanoma	1.76e-05	0.000371	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—BSG—melanoma	1.76e-05	0.000371	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—FASN—melanoma	1.76e-05	0.000371	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GPAM—melanoma	1.71e-05	0.00036	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—SLC6A11—melanoma	1.69e-05	0.000356	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PIP4K2A—melanoma	1.69e-05	0.000356	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ACER3—melanoma	1.68e-05	0.000353	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—MTAP—melanoma	1.64e-05	0.000346	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	1.61e-05	0.000338	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—HRAS—melanoma	1.54e-05	0.000325	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—UGT2B10—melanoma	1.53e-05	0.000323	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—IL6—melanoma	1.48e-05	0.000311	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PHGDH—melanoma	1.46e-05	0.000308	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—LUM—melanoma	1.46e-05	0.000308	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PLA2G6—melanoma	1.45e-05	0.000306	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—HPSE—melanoma	1.44e-05	0.000302	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—HS3ST5—melanoma	1.42e-05	0.0003	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CUBN—melanoma	1.41e-05	0.000297	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—AKT1—melanoma	1.36e-05	0.000287	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—SDHD—melanoma	1.36e-05	0.000287	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CSPG4—melanoma	1.36e-05	0.000287	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—BSG—melanoma	1.36e-05	0.000287	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GPAM—melanoma	1.32e-05	0.000278	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—VCAN—melanoma	1.3e-05	0.000275	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PLA2G6—melanoma	1.12e-05	0.000236	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYP17A1—melanoma	1.1e-05	0.000232	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PLCB4—melanoma	1.08e-05	0.000227	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GNA11—melanoma	1.04e-05	0.000219	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—FASN—melanoma	1.02e-05	0.000214	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PIP4K2A—melanoma	1.02e-05	0.000214	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—SLC6A11—melanoma	1.02e-05	0.000214	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—VCAN—melanoma	1.01e-05	0.000212	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—SLC5A5—melanoma	1e-05	0.000211	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—MTAP—melanoma	9.88e-06	0.000208	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GNAQ—melanoma	9.67e-06	0.000204	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CD44—melanoma	9.67e-06	0.000204	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	9.53e-06	0.000201	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYP1B1—melanoma	9.27e-06	0.000195	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	9.2e-06	0.000194	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PHGDH—melanoma	8.8e-06	0.000185	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—LUM—melanoma	8.8e-06	0.000185	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—HPSE—melanoma	8.63e-06	0.000182	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP17A1—melanoma	8.49e-06	0.000179	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CUBN—melanoma	8.47e-06	0.000178	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	8.38e-06	0.000176	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	8.27e-06	0.000174	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—SDHD—melanoma	8.18e-06	0.000172	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—BSG—melanoma	8.18e-06	0.000172	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CSPG4—melanoma	8.18e-06	0.000172	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GNA11—melanoma	8.02e-06	0.000169	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GPAM—melanoma	7.93e-06	0.000167	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—FASN—melanoma	7.85e-06	0.000165	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—SLC5A5—melanoma	7.72e-06	0.000163	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ABCB1—melanoma	7.63e-06	0.000161	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CD44—melanoma	7.46e-06	0.000157	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GNAQ—melanoma	7.46e-06	0.000157	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	7.3e-06	0.000154	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	7.24e-06	0.000152	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP1B1—melanoma	7.15e-06	0.000151	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PRKCA—melanoma	7.02e-06	0.000148	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ERCC2—melanoma	6.97e-06	0.000147	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PLA2G6—melanoma	6.74e-06	0.000142	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.31e-06	0.000133	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—VCAN—melanoma	6.05e-06	0.000127	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ABCB1—melanoma	5.89e-06	0.000124	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PIK3CG—melanoma	5.5e-06	0.000116	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PRKCA—melanoma	5.42e-06	0.000114	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ERCC2—melanoma	5.37e-06	0.000113	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PPARG—melanoma	5.31e-06	0.000112	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP17A1—melanoma	5.11e-06	0.000108	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PIK3CD—melanoma	4.84e-06	0.000102	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GNA11—melanoma	4.82e-06	0.000102	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ALB—melanoma	4.77e-06	0.000101	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—FASN—melanoma	4.72e-06	9.94e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—SLC5A5—melanoma	4.64e-06	9.78e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GNAQ—melanoma	4.48e-06	9.44e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CD44—melanoma	4.48e-06	9.44e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.45e-06	9.37e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP1B1—melanoma	4.3e-06	9.05e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PIK3CG—melanoma	4.24e-06	8.94e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PIK3CB—melanoma	4.22e-06	8.87e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PTGS2—melanoma	4.18e-06	8.79e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PPARG—melanoma	4.1e-06	8.62e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PIK3CD—melanoma	3.73e-06	7.86e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ALB—melanoma	3.68e-06	7.75e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PTEN—melanoma	3.64e-06	7.67e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ABCB1—melanoma	3.54e-06	7.45e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PRKCA—melanoma	3.26e-06	6.86e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PIK3CB—melanoma	3.25e-06	6.85e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ERCC2—melanoma	3.23e-06	6.8e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PTGS2—melanoma	3.22e-06	6.78e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PTEN—melanoma	2.81e-06	5.92e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PIK3CA—melanoma	2.57e-06	5.41e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PIK3CG—melanoma	2.55e-06	5.37e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PPARG—melanoma	2.46e-06	5.19e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PIK3CD—melanoma	2.24e-06	4.72e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ALB—melanoma	2.21e-06	4.66e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—AKT1—melanoma	2.1e-06	4.42e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PIK3CA—melanoma	1.98e-06	4.17e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PIK3CB—melanoma	1.96e-06	4.12e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PTGS2—melanoma	1.94e-06	4.08e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PTEN—melanoma	1.69e-06	3.56e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—AKT1—melanoma	1.62e-06	3.41e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PIK3CA—melanoma	1.19e-06	2.51e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—AKT1—melanoma	9.74e-07	2.05e-05	CbGpPWpGaD
